Matsubara, Nobuaki http://orcid.org/0000-0002-9203-4245
Kusuhara, Shota
Yamamoto, Noboru
Sudo, Kazuki
Yanagita, Masahiko
Murayama, Kosho
Kawasumi, Hisashi
Russell, Deanna L.
Yin, Da
Shimizu, Toshio
Funding for this research was provided by:
AstraZeneca
Article History
Received: 29 June 2023
Accepted: 13 October 2023
First Online: 13 December 2023
Declarations
:
: Nobuaki Matsubara has received lecture fees, honoraria, or other fees from Sanofi; and has received research funds from AbbVie, Amgen, Astellas Pharma, AstraZeneca, Bayer, Chugai Pharmaceutical, Eisai, Eli Lilly, Janssen Pharmaceutical, MSD, Pfizer, PRA Health Sciences, Roche, Seagen, Taiho Pharmaceutical, and Takeda Pharmaceutical. Shota Kusuhara has no conflicts to declare. Noboru Yamamoto has received lecture fees, honoraria, or other fees from Chugai Pharmaceutical; and has received research funds from AbbVie, Astellas Pharma, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Carna Biosciences, Chiome Bioscience, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly, Genmab, GSK, Janssen Pharmaceutical, Kyowa Kirin, Merck, MSD, Novartis, Ono Pharmaceutical, Otsuka Pharmaceutical, Pfizer, Shionogi, Sumitomo Pharma, Taiho Pharmaceutical, Takeda Pharmaceutical, and Toray Industries. Kazuki Sudo has received research funds from AstraZeneca. Masahiko Yanagita was an employee of AstraZeneca K.K. during the conduct of the study. Kosho Murayama and Hisashi Kawasumi are employees of AstraZeneca K.K. Deanna L. Russell and Da Yin are employees of AstraZeneca Pharmaceuticals. Toshio Shimizu has received payment from Chordia Therapeutics; lecture fees, honoraria, or other fees from AbbVie and Daiichi Sankyo; and research funds from 3D Medicines, AbbVie, Astellas Pharma, AstraZeneca, Bristol Myers Squibb, Chordia Therapeutics, Daiichi Sankyo, Eisai, Eli Lilly, Incyte, Loxo Oncology, Novartis, Pfizer, PharmaMar, SymBio Pharmaceuticals, and Takeda Oncology.
: The research protocol was approved by the National Cancer Center Institutional Review Board at both the National Cancer Center Hospital and the National Cancer Center Hospital East, Japan.
: Informed consent was obtained from all individual participants included in the study.